Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
about
sameAs
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?Modelling acute tolerance to the EEG effect of two benzodiazepinesTolerance to allopregnanolone with focus on the GABA-A receptor.In silico comparative genomic analysis of GABAA receptor transcriptional regulationOn-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics.Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autismCalcium/calmodulin-dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal.British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.Benzodiazepine dependence and its treatment with low dose flumazenil.GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.Use of benzodiazepines and related drugs in Manitoba: a population-based studyDifferent acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.Medication dependence and anxiety.Essential psychiatric medicines: wrong selection, high consumption and social problems.The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.Benzodiazepine-induced spatial learning deficits in rats are regulated by the degree of modulation of α1 GABA(A) receptorsThe epidemiology of long-term benzodiazepine use.Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition.Sleep-stabilizing effects of E-6199, compared to zopiclone, zolpidem and THIP in miceAcute tolerance to chlordiazepoxide qualitatively changes the interaction between flumazenil and pregnanolone and not the interaction between flumazenil and midazolam in rhesus monkeys discriminating midazolam.Chronic benzodiazepine-induced reduction in GABA(A) receptor-mediated synaptic currents in hippocampal CA1 pyramidal neurons prevented by prior nimodipine injection.Increased AMPA receptor GluR1 subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawalImidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidemNeurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study.The Importance of L-Arginine:NO:cGMP Pathway in Tolerance to Flunitrazepam in MiceDiazepam effects on non-syndromic cleft lip with or without palate: epidemiological studies, clinical findings, genes and extracellular matrix.Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.Differential effects of short- and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABA(A) receptors in vitro.Duration of treatment and activation of α1-containing GABAA receptors variably affect the level of anxiety and seizure susceptibility after diazepam withdrawal in rats.Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.βCCT, an antagonist selective for α(1)GABA(A) receptors, reverses diazepam withdrawal-induced anxiety in rats.Withdrawal from lorazepam in critically ill children.Post-hypoxic changes in rat cortical neuron GABA A receptor function require L-type voltage-gated calcium channel activation.Socio-economic determinants of drugged driving--a register-based study.Increased fear learning coincides with neuronal dysinhibition and facilitated LTP in the basolateral amygdala following benzodiazepine withdrawal in rats.Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives.The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.
P2860
Q21296639-DC39EB66-8634-4F45-B3A0-35819E485789Q24679294-2A14200B-78D1-4A34-B0C7-4A6F3CD9619BQ30471700-3C573022-29FC-4A4C-AF99-82E67D264C5EQ33289546-CBB5FF06-7494-4009-A85F-05299EC2039DQ33810643-EAAB3C91-1258-4BE3-A483-300D89DCD69AQ33837604-312D6B5E-5D11-45B8-9AAA-459D325EA322Q33998414-32EBB063-D4F2-4327-9A0D-DD0681555104Q34135759-1619B663-D756-4848-8151-F99C9CFFF0DCQ34309971-6AAB42CC-1BEF-4030-A28D-98B7018FF83AQ34389218-F3104DE6-EDD3-4E74-B9CB-C4C3CFDA9C6FQ34609374-687C2FE1-FF0C-415F-B44D-0C734137771BQ34690134-B15241F1-83AA-4EC6-ACE8-BEBFCA1B8433Q35236337-9E011224-F39B-4EE4-B4A7-8428AE517A1FQ35899624-B971DC35-6F1B-4BFF-B89C-089901BC42F8Q36011332-B29FA1C2-AB85-4B36-819C-559886D6D3CDQ36156471-4EF60456-207D-4EA5-AFC4-966770ADD659Q36252609-014A9DB3-0F42-46A8-B8D3-D649B36BE500Q36272510-41525541-C6EA-436F-A50A-BB8401E3ACBBQ36389492-A2FE0FA6-C6C3-4503-8CDC-F037EC5E46A5Q36427118-DD853609-DD94-448B-8B02-7CCC4D1F30C8Q36625643-6CEDD984-0823-4A63-A97C-6911922B0EBCQ36980929-31E8D73B-DA7B-4652-B8E7-C3761B3D5BB0Q36993994-0F9B2DA6-8B15-4C74-9639-DA53C616252AQ37012643-03366E90-DA5E-4A40-9937-76ED01589C1FQ37320505-A5611C2F-7679-4F4B-869A-F6F5D1E0B9E1Q37384693-941CED89-D14C-4CF9-838A-5B3D47D16BB8Q37586131-9B6D29E2-3128-4FA2-BA8E-DA17333610D1Q37774347-9F662F21-4444-4167-8BD8-F3F82FB67BEDQ38204833-BC816DA9-CB2B-4DB3-B2BF-A0FEE1C30958Q38787906-2756F48B-2C3C-48A5-918C-64409DC19A56Q39002171-A1CEFB1F-8BA9-4003-8DC4-4A381691ED30Q40983182-6FA43C5F-4792-416F-957C-C474D6E93948Q41438107-462FB801-87EE-45F4-8120-7B097CD1C14BQ42044694-DFBD104C-8021-40DB-BE17-534228BDC794Q42686511-40CC697D-5A2E-444A-AB3B-3B3552443089Q42950546-428B626B-5B56-4C41-A64B-3FDD239A8B4EQ44851144-119AEF1E-AB6F-4169-BADA-D122F9DF2B02Q44892560-27FFF3A1-2277-40BB-9F47-27B0A4403580Q47638812-C7CE27A6-2245-4935-AC87-7EC6B7674B82Q47798865-21BE4571-6068-418B-AD9F-1BB4D7C1DD1B
P2860
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@ast
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@en
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@nl
type
label
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@ast
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@en
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@nl
prefLabel
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@ast
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@en
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@nl
P3181
P356
P1476
Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal
@en
P2093
A N Bateson
P3181
P356
10.2174/1381612023396681
P407
P577
2002-01-01T00:00:00Z